Standards & Regulation

How can end-to-end supply chain management systems be used to prevent the movement and sale of fake and falsified medicines?

Adding authentication technologies to tablets could further help protect patients against fake drugs.

A position paper outlines why manufacturers must improve data integrity for excipients.

Can the USA boost its manufacturing capacity for critical drugs?

How is the business of making medicine changing in light of the COVID-19 pandemic?

It’s time to address the bottlenecks that lie in quality assurance review and release – and digital systems can help.

We asked medicine makers around the world to tell us how their professional and personal lives have changed during the ongoing COVID-19 crisis.

A dispersible tablet could open up treatment options for pediatric patients, according to Harmony Grages, Chief Medical Officer at ViiV Healthcare.

How can pharma companies keep up with the rapidly changing Chinese regulatory landscape?

The EMA is offering scientists free advice on the development of therapeutics to treat COVID-19.